Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 173 publications
Third-Party Viral Specific T Cells for Immunocompromised Hosts and Access Barriers: A Review and Commentary by an Expert Panel from ASTCT.
Journal: Transplantation and cellular therapy
Published: April 19, 2026
Third-Party Viral Specific T cells for Immunocompromised Hosts and Access Barriers: A Review and Commentary by an Expert Panel from ASTCT.
Journal: Transplantation and cellular therapy
Published: April 19, 2026
Erratum: Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 31, 2026
Introduction to a review series on hemophagocytic lymphohistiocytosis.
Journal: Blood
Published: December 29, 2025
Autologous multiantigen-targeted T cell therapy for pancreatic cancer: a phase 1/2 trial.
Journal: Nature medicine
Published: May 16, 2025
Differential EBV protein-specific antibody response between responders and non-responders to EBVSTs immunotherapy.
Journal: bioRxiv : the preprint server for biology
Published: August 30, 2024
Time to optimize vaccination strategies in blood cancer patients.
Journal: British journal of haematology
Published: June 03, 2024
Efficacy of Letermovir for Cytomegalovirus Prophylaxis Following Alemtuzumab T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplant.
Journal: Transplantation and cellular therapy
Published: May 28, 2024
Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 21, 2024
Last Updated: 09/26/2026